Ocular Therapeutix's eye-drop replacing punctum plug looks promising at 2 months

Tue, 10/30/2012 - 12:44pm
Mass Device

Ocular Therapeutix affirms 2-month safety and effectiveness for its drug-eluting intracanalicular plug in treatment of glaucoma and ocular hypertension.

Ocular Therapeutix logo

Ocular Therapeutix touted 2-month clinical results for its glaucoma and ocular hypertension treating eye plug, a sustained-release drug-eluting punctum plug.

In a 20-patient clinical trial conducted in South Africa, researchers reported reduced intraocular pressure at 2 months with no excessive tearing or unanticipated adverse events, according to a press release. Findings were similar to treatment with topical brand name ophthalmic solutions, Ocular noted.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.